ClearBridge Investments - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$125,572,000
+3.7%
830,668
-0.0%
0.13%
+12.4%
Q2 2022$121,052,000
-11.4%
830,776
-27.9%
0.11%
+9.7%
Q1 2022$136,572,000
+13.6%
1,151,829
+32.0%
0.10%
+25.6%
Q4 2021$120,249,000
-0.7%
872,570
+0.1%
0.08%
-4.7%
Q3 2021$121,098,000
+42.7%
871,776
-0.3%
0.09%
+45.8%
Q2 2021$84,878,000
+64.0%
874,314
+15.4%
0.06%
+51.3%
Q1 2021$51,764,000
+13.2%
757,340
+41.9%
0.04%
+11.4%
Q4 2020$45,738,000
+90.6%
533,631
+44.6%
0.04%
+66.7%
Q3 2020$23,999,000
+17.5%
369,156
+32.2%
0.02%
+16.7%
Q2 2020$20,423,000279,3450.02%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders